Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-24

Clinical Trial Update: Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Danshu Capsule and Ursodeoxycholic Acid Capsule for preventing recurrence of choledocholithiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danshu Capsule
  • Ursodeoxycholic Acid Capsule (ursodeoxycholic acid)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Choledocholithiasis, Recurrence | Phase 4 | Status: COMPLETED